<?xml version="1.0" encoding="UTF-8"?>
<ref id="B100-vaccines-07-00053">
 <label>100.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Finberg</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Lanno</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Fleischhackl</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>van Duijnhoven</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Kauffman</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Kosoglou</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Vingerhoets</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Leopold</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial</article-title>
  <source>J. Infect. Dis.</source>
  <year>2019</year>
  <volume>219</volume>
  <fpage>1026</fpage>
  <lpage>1034</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiy547</pub-id>
  <?supplied-pmid 30428049?>
  <pub-id pub-id-type="pmid">30428049</pub-id>
 </element-citation>
</ref>
